Calendar

Week of Sep 29, 2025

Sep 30, 2025grant334d agoUNIVERSITY OF CALIFORNIA BERKELEY — Evaluation of State-Level Sexual and Gender Minority Laws for the Primary Pre...

CE grant. $500,000. PI: Sabrina Christine Boyce

full page →nih reporter ↗

Sep 30, 2025grant334d agoLO BIOSCIENCES, INC. — A novel remote blood separation device for at-home plasma collection for HIV-...

PS grant. $994,658. PI: Maria de los Angeles JAIME

full page →nih reporter ↗

Sep 30, 2025grant334d agoMASSACHUSETTS GENERAL HOSPITAL — High-Dose Medications for Opioid Use Disorder: Effects on Treatment Retention...Massachusetts General Hospital

CE grant. $348,837. PI: Huiru Dong

full page →nih reporter ↗

Sep 30, 2025grant334d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — CE25-021 - Development and Rigorous Evaluation of Culturally Grounded Crime P...

CE grant. $400,000. PI: Katie M Edwards

full page →nih reporter ↗

Sep 30, 2025grant334d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarke...University of Utah

AG grant. $5,789,766. PI: Adam P Bress

full page →nih reporter ↗

Sep 30, 2025grant334d agoSTANFORD UNIVERSITY — Effects of Health Shocks at Older Age on Older Adults and their Families: New...Stanford University

AG grant. $620,020. PI: Maria Polyakova

full page →nih reporter ↗

Sep 30, 2025grant334d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Lifestyle Change Implementation Research Network at PRC at UMass Chan

DP grant. $499,993. PI: Jamie Faro

full page →nih reporter ↗

Sep 30, 2025grant334d agoGEORGE MASON UNIVERSITY — Preventing intimate partner violence among refugee populations in the United ...

CE grant. $374,759. PI: Jhumka Gupta

full page →nih reporter ↗

Sep 30, 2025grant334d agoSTANFORD UNIVERSITY — Peripheral nervous system agingStanford University

AG grant. $1,123,001. PI: ANNE BRUNET

full page →nih reporter ↗

Sep 30, 2025grant334d agoUNIVERSITY OF MINNESOTA — Defining the role of Fzd6 in lymphatic network development and functionUniversity of Minnesota

HL grant. $35,375. PI: Evalyn Beall

full page →nih reporter ↗

Sep 30, 2025grant334d agoUNIVERSITY OF NOTRE DAME — Combining ecological momentary assessment and qualitative methods to construc...

AA grant. $49,538. PI: Melissa Nance

full page →nih reporter ↗

Sep 30, 2025grant334d agoOHIO STATE UNIVERSITY — Mechanisms of neuronal TRPM2 channel effects on Post-Stroke Cognitive Impairment

NS grant. $44,916. PI: Kelley A. Coakley

full page →nih reporter ↗

Sep 30, 2025grant334d agoSTANFORD UNIVERSITY — Unveil the functional role of RNA spatial localization in neuronal function a...Stanford University

NS grant. $49,538. PI: Maylin Fu

full page →nih reporter ↗

Oct 1, 2025approval333d agoVONJO (PACRITINIB CITRATE) — FDA approvalpacritinib

Sponsor: SOBI. Form: CAPSULE. Route: ORAL

full page →pacritinib →fda approvals ↗

Oct 1, 2025approval333d agoMORPHINE SULFATE — FDA approvalKapanol

Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →Kapanol →fda approvals ↗

Oct 1, 2025approval333d agoHYDROMORPHONE HYDROCHLORIDE — FDA approvalSpecGx LLC

Sponsor: PADAGIS US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: GRANULES. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 1, 2025approval333d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 1, 2025approval333d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Oct 1, 2025approval333d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Oct 1, 2025approval333d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Oct 1, 2025approval333d agoFLUOCINOLONE ACETONIDE — FDA approvalEclipse Life Sciences Inc

Sponsor: PADAGIS ISRAEL. Form: OIL. Route: TOPICAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoFLUOCINOLONE ACETONIDE — FDA approvalEclipse Life Sciences Inc

Sponsor: PADAGIS ISRAEL. Form: OIL/DROPS. Route: OTIC

full page →fda approvals ↗

Oct 1, 2025approval333d agoDORZOLAMIDE HYDROCHLORIDE — FDA approvalDORZOLAMIDE HYDROCHLORIDE

Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →DORZOLAMIDE HYDROCHLORIDE →fda approvals ↗

Oct 1, 2025approval333d agoDORZOLAMIDE HYDROCHLORIDE — FDA approvalDORZOLAMIDE HYDROCHLORIDE

Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →DORZOLAMIDE HYDROCHLORIDE →fda approvals ↗

Oct 1, 2025approval333d agoDIAMOX (ACETAZOLAMIDE) — FDA approvalAccord Healthcare Inc

Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoPREDNISONE — FDA approvalVintage Pharmaceuticals Inc (Inactive)

Sponsor: DR REDDYS. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: ANNORA PHARMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Oct 1, 2025approval333d agoLETROZOLE — FDA approvalLETROZOLE

Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

full page →LETROZOLE →fda approvals ↗

Oct 1, 2025approval333d agoLETROZOLE — FDA approvalLETROZOLE

Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

full page →LETROZOLE →fda approvals ↗

Oct 1, 2025approval333d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: ACS DOBFAR SPA. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

Oct 1, 2025approval333d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: ACS DOBFAR SPA. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

Oct 1, 2025approval333d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

full page →PANTOPRAZOLE SODIUM →fda approvals ↗

Oct 1, 2025approval333d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

full page →PANTOPRAZOLE SODIUM →fda approvals ↗

Oct 1, 2025approval333d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

full page →PANTOPRAZOLE SODIUM →fda approvals ↗

Oct 1, 2025approval333d agoANTARA (MICRONIZED) (FENOFIBRATE) — FDA approvalFENOFIBRATE

Sponsor: LUPIN. Form: CAPSULE. Route: ORAL

full page →FENOFIBRATE →fda approvals ↗

Oct 1, 2025approval333d agoPREGABALIN — FDA approvalCreekwood Pharmaceutical Inc

Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoPREGABALIN — FDA approvalCreekwood Pharmaceutical Inc

Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoPREGABALIN — FDA approvalCreekwood Pharmaceutical Inc

Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 1, 2025approval333d agoDOXYCYCLINE — FDA approvaldoxycycline ER

Sponsor: AIPING PHARM INC. Form: CAPSULE. Route: ORAL

full page →doxycycline ER →fda approvals ↗

Oct 1, 2025approval333d agoIRBESARTAN — FDA approvalIRBESARTAN

Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

full page →IRBESARTAN →fda approvals ↗

Oct 1, 2025approval333d agoMIUDELLA (COPPER) — FDA approval

Sponsor: SEBELA WOMENS HLTH. Form: SYSTEM. Route: INTRAUTERINE

full page →fda approvals ↗

Oct 1, 2025recall333d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52 — Reason: CGMP Deviations: Market complaints received for gritty texture (grainy) — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 oz (201g) Uptown Medi Spa, Phoenix, AZ. — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoConsumer Product Partners, LLC recall (Cls III)KROGER CO

TopCare Health 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 36800-589-14 — Reason: Cross Contamination with Other Products. — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoConsumer Product Partners, LLC recall (Cls III)KROGER CO

Kroger 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 30142-810-14 — Reason: Cross Contamination with Other Products. — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of Skin Beverly Hills, CA 90210 — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoGranules Pharmaceuticals Inc. recall (Cls III)LB PHARMACEUTICALS INC

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing

full page →fda recalls ↗

Oct 1, 2025recall333d agoPrivate Label Skin Care Inc. recall (Cls II)Galderma Laboratories LP

mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210 — Reason: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products. — Status: Ongoing

full page →fda recalls ↗

← prev

page 68 of 361

Week of Sep 29, 2025